Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Role of the lncRNA complex HCP5 in glioma treatment

Nitrogen dioxide reduction leads to an increase in crop yield

Olfactory Implants on the rise to fix the dysfunctional system

Role of the lncRNA complex HCP5 in glioma treatment
  • BiotechToday
  • World

Role of the lncRNA complex HCP5 in glioma treatment

bioxone July 7, 2022July 7, 2022

Harini Balasubramanian, Anna University, Chennai

The investigation of non-coding regions of the DNA, especially miRNA and long non-coding RNA (lncRNA), and their role in various disease phenotypes, has drawn the attention of scientists in recent years. Gliomas are neoplasias usually found in the brain, a stage IV progression of which leads to glioblastoma (GBM). GBM is highly fatal with a median survival rate of merely 15 months. It is therefore essential that for a better understanding of the disease progression, more studies need to be conducted.

LncRNAs have been found to interact with miRNAs — short non-coding RNAs with up to 22 nucleotides. miRNAs regulate most of the post-transcriptional gene expression in a cell – to either stimulate malignancy or tumor suppression. lncRNA HLA complex P5 (HCP5) has been discovered to have carcinogenic properties by promoting cell proliferation, migration, and angiogenesis in follicular thyroid carcinoma cells. miR-205 is a miRNA of interest in this study, given its tumor-suppressive properties in gliomas, as established in previous studies.

So, this study investigated the previously unexplored role of HCP5 in glioma progression. Also, it further investigated the interaction of HCP5 with miR-205 and their combined molecular mechanisms along the VEGF-A axis (an essential factor in vascularizing tumors) in affecting glioma progression. 

Methodology:

  1. RNA Sequencing, Data processing, Analysis
  2. The culture of a patient’s primary GBM cell line (U251), Normal Human Astrocyte (NHA), and tumor tissue were obtained from patient.
  3. Cell transfection: siRNA against HCP5, miR-205 mimics, and negative control mimics were synthesized. Vectors for shRNA targeting HCP5 and the human VEGF-A gene were transfected into primary GBM cells.
  4. Cell viability assay, scratch wound healing assay for cell migration and invasiveness, and cell proliferation assays were conducted.
  5. In vivo xenograft study in mice was performed by injecting them subcutaneously with U251 cells post-transfection.
  6. qRT-PCR was performed to quantify expression levels of HCP5, miR-205, and VEGF-A.
  7. Western Blot analysis was done to primarily quantify VEGF-A protein concentration.

Outcome & Inference:

In different types of cancers, HCP5 was found to be significantly more upregulated compared to healthy control samples. The RNA sequencing data derived from TCGA projects also revealed the prognosis and thereby, that the survival rate had a negative correlation with expression levels 0f HCP5. For gliomas, in particular, the results showed that overexpression of HCP5 may be implicated in glioma progression.

Conversely, it also proved that in cells with siRNA transfection and subsequent HCP5 knockdown, its downregulation prominently mitigated cell viability and migration. In vivo studies also showed slowed tumor growth in mice injected with HCP5-silenced GBM cells.

In addition, HCP5’s interaction with miR-205 downregulated (relative to NHA cell line) the former’s expression in GBM cell lines. It was also found that miR-205 expression has an inverse relationship with HCP5, as the latter-silenced GBM cells had elevated levels of miR-205.

Regarding the feedback loop modulating GBM progression, the researchers determined that HCP5 downregulation was strongly associated with the downregulation of VEGF-A, both of which strikingly decreased upon upregulation of miR-205. So, they ascertained that by targeting miR-205, HCP5 modulated the expression of VEGF-A.

The results of this study, therefore, provide potential theragnostic targets for glioma treatment and specific drug development.

Reference:

Cheng, R., Ji, L., Su, H., Wang, L., Jia, D., Yao, X. and Ji, H. Silencing of Long Noncoding RNA HLA Complex P5 (HCP5) Suppresses Glioma Progression through the HCP5-miR-205-Vascular Endothelial Growth Factor A Feedback Loop. BioMed Research International, 2022. https://pubmed.ncbi.nlm.nih.gov/35769676/

Also read: Nitrogen dioxide reduction leads to an increase in crop yield

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged feedback mechanism Glioma glioma treatment HCP5 lncRNA lncRNA complex miRNA transcriptomics Prognosis vascularization

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Olfactory Implants on the rise to fix the dysfunctional system

BioTech Today July 9, 2022

Jaladhi Shah, Dr D. Y. Patil Biotechnology and Bioinformatics Institute, Pune The aftermath of COVID-19 on the olfactory system: Following the multiple waves of COVID-19 that the world has witnessed, a lot of people, infected or uninfected have been subject to making changes in their lives. One such lifestyle adjustment that a lot of COVID-19 […]

Olfactory Implants

Related Post

  • BiotechToday
  • World

Haemodynamic Frailty: A threat

bioxone July 17, 2021July 17, 2021

Sayak Banerjee, Amity University Kolkata Haemodynamic Frailty and its associated disorders Frailty is defined as a clinically recognized state of increased vulnerability causing an ageing-associated functional decline in the advancing years. This decline takes place across several physiological systems resulting in compromised acute stressors. It is a pre-morbid condition in which the individual is in […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Gel-mediated drug delivery- A breakthrough in treating Brain disorders

bioxone June 10, 2021June 12, 2021

Sampriti Roy, University of Calcutta When we see conventional drug administration, especially in cases of neurodegenerative diseases like Parkinson’s, the commonly prescribed drugs are those that require metabolism to be absorbed into the central nervous system. However, it has been found that the number of drugs reaching the brain after metabolism is very small. We […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

None of the SARS-CoV-2 Genetic Mutations Appear to Increase Transmissibility

bioxone December 2, 2020December 2, 2020

SAGNIK NAG, Amity University, Kolkata SARS-CoV-2 is a type of RNA virus, which can develop mutations by three different ways: by making mistake from copying errors during viral replication, through interactions with other viruses infecting the same cell i.e. recombination, or they can be also induced by host RNA modification systems which are part of […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy